Lifestyle Interventions for Gestational Diabetes
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently taking Metformin or took it within 3 months before conception.
What data supports the effectiveness of the GDM Prevention Program treatment for gestational diabetes?
Research shows that lifestyle interventions, which include changes in diet and physical activity, can help prevent gestational diabetes and reduce the risk of developing Type 2 diabetes later. These interventions have been found to be feasible and potentially effective, especially when delivered by trained facilitators.12345
Is the lifestyle intervention for gestational diabetes safe for humans?
Lifestyle interventions, which include changes in diet, physical activity, and behavior, have been tested in various studies and are generally considered safe for humans. These interventions have been used to manage weight and reduce the risk of developing diabetes and other health issues, with no significant safety concerns reported.46789
How is the GDM Prevention Program treatment different from other treatments for gestational diabetes?
The GDM Prevention Program is unique because it focuses on lifestyle changes, such as diet and physical activity, to prevent gestational diabetes, rather than relying on medication. This approach aims to help women manage their weight and health behaviors before, during, and between pregnancies to reduce the risk of developing gestational diabetes.1291011
What is the purpose of this trial?
The goal of this study is assess the impact of a higher intensity dietary and activity counseling program to improve blood sugar control and reduce the chance of developing gestational diabetes (GDM) as compared to the current standard diet and activity counseling.
Eligibility Criteria
This trial is for pregnant individuals at or before 16 weeks and 6 days, aged 35+, with a family history of diabetes, BMI of 30 or more, or Hemoglobin A1c between 5.9% to 6.4%. It excludes those with major fetal anomalies, multiple gestations, chronic steroid use (except inhaled/short-term), current/pre-pregnancy Type 1/2 diabetes diagnosis, recent Metformin use, or inability to consent in English/Spanish.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized into either standard care or a more intensive GDM prevention program, involving dietary and activity counseling, wearing activity trackers, and continuous glucose monitoring
Follow-up
Participants are monitored for safety and effectiveness after treatment, including blood draws to measure hemoglobin A1c, lipids, and HOMA-IR measures
Treatment Details
Interventions
- GDM Prevention Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
Northeastern University
Collaborator
University of Texas
Collaborator